REDWOOD SHORES, Calif.--(BUSINESS WIRE)--Mar. 12, 2015--
Imperva, Inc. (NYSE: IMPV) today announced the pricing of its
underwritten registered public follow-on offering of 3,000,000 shares of
its common stock at a price to the public of $39.00 per share. Imperva
also granted the underwriters a 30-day option to purchase up to an
additional 450,000 shares of its common stock. The offering is expected
to close on March 18, 2015, subject to customary closing conditions.
Imperva expects to use the net proceeds from the offering for working
capital and other general corporate purposes, which may include
acquisitions of businesses, technologies or other assets, although
Imperva currently has no agreements or commitments relating to specific
acquisitions at this time. Morgan Stanley & Co. LLC, Deutsche Bank
Securities Inc., RBC Capital Markets LLC and Pacific Crest Securities
LLC are acting as bookrunners for the offering. Macquarie Capital (USA)
Inc. and Nomura Securities International, Inc. are acting as co-managers.
An effective registration statement relating to these securities was
filed with the Securities and Exchange Commission on March 9, 2015. The
offering is being made only by means of an effective shelf registration
statement, including a preliminary prospectus, and final prospectus,
copies of which may be obtained by contacting Morgan Stanley & Co. LLC,
Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New
York, NY 10014.
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy, nor shall there be any sale of these
securities in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such state or
Source: Imperva, Inc.
Investor Relations Contact: